ondansetron has been researched along with Post-Dural Puncture Headache in 4 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Post-Dural Puncture Headache: A secondary headache disorder attributed to low CEREBROSPINAL FLUID pressure caused by SPINAL PUNCTURE, usually after dural or lumbar puncture.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ondansetron is a 5-HT3 receptor antagonist which is generally used for the prophylactic management of nausea and vomiting; however, studies have found that ondansetron might decrease the incidence of PDPH." | 6.80 | Effect of ondansetron on post-dural puncture headache (PDPH) in parturients undergoing cesarean section: a double-blind randomized placebo-controlled study. ( Fattahi, Z; Hadavi, SM; Sahmeddini, MA, 2015) |
| "Ondansetron is a 5-HT3 receptor antagonist which is generally used for the prophylactic management of nausea and vomiting; however, studies have found that ondansetron might decrease the incidence of PDPH." | 2.80 | Effect of ondansetron on post-dural puncture headache (PDPH) in parturients undergoing cesarean section: a double-blind randomized placebo-controlled study. ( Fattahi, Z; Hadavi, SM; Sahmeddini, MA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, G | 1 |
| Song, G | 1 |
| Liu, J | 1 |
| Bordlee, JW | 1 |
| Beakley, BD | 1 |
| Mody, R | 1 |
| McConville, AP | 1 |
| Weed, JT | 1 |
| McClure, BP | 1 |
| Foldes, PJ | 1 |
| Ma, JG | 1 |
| Kaye, AD | 1 |
| Eskander, JP | 1 |
| Fattahi, Z | 1 |
| Hadavi, SM | 1 |
| Sahmeddini, MA | 1 |
| Sharma, R | 1 |
| Panda, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Efficacy of Neostigmine as an Adjuvant to Bupivacaine for Intrathecal Block in Reducing the Incidence and Severity of Post-Dural Puncture Headache for Parturients Scheduled for Elective Caesarean Section[NCT03587441] | Phase 4 | 240 participants (Actual) | Interventional | 2018-08-04 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ondansetron and Post-Dural Puncture Headache
| Article | Year |
|---|---|
Efficacy of pharmacological therapies for preventing post-dural puncture headaches in obstetric patients: a Bayesian network meta-analysis of randomized controlled trials.
Topics: Bayes Theorem; Cesarean Section; Female; Humans; Network Meta-Analysis; Ondansetron; Post-Dural Punc | 2023 |
1 trial available for ondansetron and Post-Dural Puncture Headache
| Article | Year |
|---|---|
Effect of ondansetron on post-dural puncture headache (PDPH) in parturients undergoing cesarean section: a double-blind randomized placebo-controlled study.
Topics: Adult; Anesthesia, Spinal; Antiemetics; Cesarean Section; Double-Blind Method; Female; Humans; Hypot | 2015 |
2 other studies available for ondansetron and Post-Dural Puncture Headache
| Article | Year |
|---|---|
A case of paradoxical presentation of a postural postdural puncture headache after combined spinal-epidural anesthesia.
Topics: Acetaminophen; Adult; Analgesics, Opioid; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, | 2017 |
Ondansetron-induced headache in a parturient mimicking postdural puncture headache.
Topics: Adult; Antiemetics; Cesarean Section; Diagnostic Errors; Female; Headache; Humans; Ondansetron; Post | 2010 |